Menu
Not yet recruiting NCT07177768

Acute Effects of Prolonged Walking on Hallux Valgus

No phase Interventional Hallux Valgus

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Prolonged walking.
Who it may be relevant to
Registry conditions: Hallux Valgus. Basic parameters: 18 years — 55 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Acute Effects of Prolonged Walking on Pain, Balance and Posture in Individuals With Hallux Valgus Deformity

Overview

Hallux valgus is a progressive foot deformity characterized by lateral deviation of the great toe and medial displacement of the first metatarsal head. While pain is a common symptom among individuals with HV, alterations in plantar pressure distribution and impaired balance are also frequently observed. These symptoms and biomechanical changes can negatively impact posture and gait mechanics. The aim of this study is to investigate the acute effects of prolonged walking on pain, balance, posture, and gait in individuals with hallux valgus deformity.

Detailed description

Hallux valgus is a progressive foot deformity commonly seen in adults. Patients typically report pain, most prominently in the first metatarsophalangeal joint, which is often exacerbated by weight-bearing activities such as walking. Due to the deformity, alterations in plantar pressure distribution occur, which in turn affect plantar sensory input and postural control. This may lead to decreased postural stability, impaired balance, and compromised control during walking. HV is also thought to accelerate biomechanical changes that negatively impact gait patterns. The aim of this study is to evaluate the acute effects of prolonged walking on pain, balance, posture, and gait in individuals with hallux valgus deformity. A total of 32 participants, including individuals with HV and healthy controls, will be included in the study. All participants will walk on a treadmill for 60 minutes. Assessments will be conducted at three time points: before walking, immediately after walking, and 20 minutes post-walking.

Interventions

  • Other Prolonged walking
    walking on a treadmill for 60 minutes

Primary outcome measures

  • Pain intensity [Time frame: Baseline, immediately after intervention, 20 minutes after intervention]
  • Pressure pain threshold [Time frame: Baseline, immediately after intervention, 20 minutes after intervention]
  • Single-leg stance test [Time frame: Baseline, immediately after intervention, 20 minutes after intervention]
  • Postural Assessment [Time frame: Baseline, immediately after intervention, 20 minutes after intervention]
  • Gait analysis [Time frame: Baseline, immediately after intervention, 20 minutes after intervention]

Eligibility criteria

Inclusion criteria

Hallux Valgus Group Criteria:

  • Individuals aged between 18 and 55 years
  • Being diagnosed with hallux valgus

Control Group Criteria:

  • Individuals aged between 18 and 55 years
  • Classified as grade A according to the Manchester Scale
  • Being a volunteer

Exclusion criteria

  • History of previous foot or ankle surgery
  • Having a systemic diseases
  • Having a neurological disorders
  • Having a vestibular pathologies that may affect balance

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Other

Study locations

Turkey (Türkiye) · 1 center
  • Bezmialem Vakif University — Istanbul

Identifiers

NCT: NCT07177768 · KA25-2

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗